LEADERSHIP TEAM

Andre Pontin

Chief Executive Officer

Andre is an experienced healthcare executive with a proven track record in creating strategic partnerships, scaling startups, large enterprise sales agreements, business development and product innovation.

Frank Manion, PhD

VP for Innovation

Dr. Manion, VP for Innovation, has held executive positions in biomedical informatics support at two major NCI-designated comprehensive cancer centers. He served as Chief Technology Officer and Deputy CIO at the Fox Chase Cancer Center.

Hao Ding, PhD

Director of Operations

A biophysicist by training, Dr. Hao Ding was fascinated by natural language processing, machine learning, and the impact of new technology that will bring to the healthcare industry. Dr. Ding has been passionate about expanding business development.

Liang-Chin Huang, PhD

Senior Data Scientist

Dr. Liang-Chin Huang is experienced in building knowledge graphs and developing the drug-repurposing framework as Senior Data Scientist at Melax Tech.

Jingqi Wang, PhD

Chief Technology Officer

Dr. Jingqi Wang serves as the Chief Technology Officer at Melax Tech, leading the NLP development team. He has ten years of working experience as a software developer before he joined Melax.

Howard Lei

VP of Business Development

Howard Lei is the VP of Business Development at Melax Tech with 20 years experience in leading major engagement for Fortune 500 companies.

Cynthia Freeney

Project Manager and Security Officer

Cynthia Freeney is Melax Tech’s Project Manage and Security Officer. A naturally curious individual, Cynthia has varied experience in the software development space and has held many roles.

Augustine Annan, PhD

Senior Data Scientist

Dr. Augustine Annan is experienced in developing AI and NLP algorithms in the biomedical domain as Senior Data Scientist at Melax Tech.

Xiaoyan Wang, PhD

Chief Scientific Officer

Dr. Xiaoyan Wang serves as Melax Tech’s Chief Scientific Officer. As CSO, she focuses on translating scientific insights and health intelligence into partnerships and programs that improve healthcare outcomes for patients, providers, and researchers.

Jingcheng Du, PhD

Director of NLP Research

Dr. Du serves as the Director of Natural Language Processing at Melax Tech, and Adjunct Assistant Professor at University of Texas Health School of Biomedical Informatics, additionally.

Kyeryoung Lee, PhD

Principal Scientist

Dr. Kyeryoung Lee is an experienced clinical domain expert in the Natural Language Processing (NLP) field and serves as a Principal Scientist at Melax Tech.

Surabhi Datta, PhD

Senior NLP Scientist

Dr. Surabhi Datta is a Senior NLP Scientist at Melax Tech, where she designs new NLP methods to extract important information from unstructured biomedical and clinical data for healthcare applications.

Hua Xu, PhD

Founder

Dr. Hua Xu is the Founder of Melax Technologies Inc. He earned his Ph.D. in Biomedical Informatics from Columbia University and currently serves as a Professor and Vice-Chair at the Section of Biomedical Informatics and Data Science, as well as the Assistant Dean for Informatics at Yale University's School of Medicine.

Previously, Dr. Xu held the position of Professor and Director of Center for Translational AI in Medicine at The University of Texas Health Science Center in Houston, TX. Over the past decade,

he has tackled numerous challenging topics in natural language processing (NLP), and his lab's clinical NLP methods and systems have been widely acclaimed. Dr. Xu has served as the Chair of AMIA NLP Working Group and currently leads the NLP Working Group at OHDSI.

LEADERSHIP TEAM

FOUNDER

Hua Xu, PhD